bt200
Nucleic acidexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Oct 14, 2019 (NCT04103034)
Timeline
Indications
Mechanism of action
- von Willebrand factorACTIVATOR
VWF activator
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07273721 | Phase 2 | Aug 14, 2025 | Medical University of Vienna |
| NCT04677803 | Phase 2 | Dec 14, 2020 | Medical University of Vienna |
| NCT04103034 | Phase 1 | Oct 14, 2019 | Band Therapeutics, Medical University of Vienna |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Medical University of Vienna | Academic/Hospital | 3 | 2 | 2 | 2019 |
| Band Therapeutics | For profit | 1 | 1 | 1 | 2019 |
2 organizations
Page 1 / 1